Richard Pilnik speaks with GLG (Gerson Lehrman Group) about how health care systems in emerging markets can vary and how Type 2 Diabetes treatment is handled differently across various health systems.
Until recently, Richard Pilnik served as EVP and President of Quintiles Global Commercial Solutions, focusing on the Pharmaceutical Industry covering 65+ Pharma/Biosciences companies located in the USA, Europe, Japan and emerging markets. Richard also worked as Group VP, Chief Marketing Officer at Eli Lilly and Company, including 25 years working and living in Latin America, Europe, USA and Asia.
Richard's Board experience includes Elan Pharmaceuticals, Diamedica (a Canadian biotech company) and Fuqua School of Business at Duke University.
Subscribe to the GLG Channel: [ Ссылка ]
Connect with GLG (Gerson Lehrman Group) Online:
Visit our Website: [ Ссылка ]
Follow us on Twitter: [ Ссылка ]
Find us on LinkedIn: [ Ссылка ]
Like us on Facebook: [ Ссылка ]
Connect with us on Instagram: [ Ссылка ]
